Daily News Podcast

Opioids don’t top NSAIDs for chronic pain

Publish date: December 20, 2018

 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Pot for chronic pain? The jury is still out
MDedge Internal Medicine
Harnessing the power of urine tests in pain care
MDedge Internal Medicine
Opioids appear safe for sickle cell pain
MDedge Internal Medicine
Comorbid TBI & PTSD raise the risk for sleep disturbances, pain
MDedge Internal Medicine
A case of cold burn reported with whole-body cryotherapy
MDedge Internal Medicine
“FAST” indices help to identify fibromyalgia in routine rheumatology care
MDedge Internal Medicine
USPSTF issues draft research plan on opioid use disorder prevention
MDedge Internal Medicine
Rheumatologist prescribing rates predict chronic opioid use in RA patients
MDedge Internal Medicine
Opioid benefit small in chronic noncancer pain
MDedge Internal Medicine
Insulin loses its starting spot
MDedge Internal Medicine